Duloxetine overdose

February 2011
Reactions Weekly;2/19/2011, Issue 1339, p19
Case Study
The article describes the case of a 49-year-old man who went into a coma following an intentional duloxetine overdose.


Related Articles

  • Therapy for Chemotherapy-Induced Peripheral Neuropathy. Seretny, Marta; Colvin, Lesley; Fallon, Marie; Lavoie Smith, Ellen M.; Pang, Herbert // JAMA: Journal of the American Medical Association;8/7/2013, Vol. 310 Issue 5, p537 

    A letter to the editor is presented in response to the article "Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial" and also presents a response from authors.

  • Rivaroxaban: Another Warfarin Replacement.  // Travel Medicine Advisor;Jan2011 Supplement, p1 

    The article offers news briefs related to pharmacology in the U.S. A study shows that rivaroxaban, an oral drug factor Xa inhibitor, is as effective as warfarin in preventing stroke and blood clots in patients with nonvalvular atrial fibrillation. A study published in "Annals of Internal...

  • Symptomatic hyponatremia during glomerular filtration rate testing. Balaram, Manjunath; Ford, Virginia; Townsend, Raymond // NDT Plus;Dec2010, Vol. 3 Issue 6, p539 

    Hyponatremia affects nearly one in five of all hospitalized patients. Severe hyponatremia is associated with significant morbidity and mortality, and is therefore important to recognize. Prior reports have linked duloxetine with hyponatremia, but it is uncommon. In this case report, we describe...

  • Results of switching to milnacipranin fibromyalgia patients with an inadequate response to duloxetine: a phase IV pilot study. Bateman, Lucinda; Palmer, Robert H.; Trugman, Joel M.; Yuhua Lin // Journal of Pain Research;2013, Vol. 6, p311 

    Background: The purpose of this study was to evaluate the safety, tolerability, and efficacy of milnacipran following a direct switch from duloxetine in fibromyalgia patients experiencing inadequate clinical response to duloxetine after receiving treatment for 6 weeks or longer. Methods: This...

  • Real-world treatment patterns and opioid use in chronic low back pain patients initiating duloxetine versus standard of care. Andrews, Jeffrey Scott; Ning Wu; Shih-Yin Chen; Xia Yu; Xiaomei Peng; Novick, Diego // Journal of Pain Research;2013, Vol. 6, p825 

    To describe the use of pain medications in patients with chronic low back pain (CLBP) after initiating duloxetine or standard of care (SOC [muscle relaxants, gabapentin, pregabalin, venlafaxine, and tricyclic antidepressants]) for pain management, pharmacy and medical claims from Surveillance...

  • Author's reply. Spence, Des // BMJ: British Medical Journal;2/22/2014, Vol. 348 Issue 7946, p20 

    The article discusses the need for healthcare professionals to go beyond the traditional definition of pain, as it is cultural, not merely medical and it is the major medically unexplained symptom.

  • Prognosis in nontraumatic coma. Levy, David E.; Bates, David; Caronna, John J.; Cartridge, Niall E.T; Robin, M.B.; Jones, P. Knill; Lapinski, Robert H.; Singer, Borton H.; Shaw, David A.; Plum, Fred; Levy, D E; Bates, D; Caronna, J J; Cartlidge, N E; Knill-Jones, R P; Lapinski, R H; Singer, B H; Shaw, D A; Plum, F // Annals of Internal Medicine;Mar81, Vol. 94 Issue 3, p293 

    We conducted serial neurologic examinations on 500 patients in nontraumatic coma to identify factors predicting recovery. Overall, 81 patients (16%) led an independent life at some point within the first year; the remainder either died without recovery from coma (61%), never improved beyond the...

  • Management of Painful Symptoms with Duloxetine: A Review of the Efficacy in Pre-Clinical and Clinical Studies. Robinson, Michael J.; Ahl, Jonna; Meyers, Adam L.; McCarberg, Bill H.; Iyengar, Smriti // Current Drug Therapy;May2011, Vol. 6 Issue 2, p121 

    This is a review of the effect of duloxetine on pain in pre-clinical studies as well as in clinical studies in patients with diabetic peripheral neuropathic pain (DPNP) and fibromyalgia (FM), and painful symptoms associated with major depressive disorder (MDD) and generalized anxiety disorder...

  • Benefits and harms in clinical trials of duloxetine for treatment of major depressive disorder: comparison of clinical study reports, trial registries, and publications. Maund, Emma; Tendal, Britta; Hróbjartsson, Asbjørn; Jørgensen, Karsten Juhl; Lundh, Andreas; Schroll, Jeppe; Gøtzsche, Peter C. // BMJ: British Medical Journal;6/14/2014, Vol. 348 Issue 7962, p11 

    The article discusses a study that compared clinical study reports (CSR), trial registries and publications on the benefits and harms in clinical trials of duloxetine for major depressive disorder. Findings include the inconsistencies in reported harms between summaries and tabulations of data...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics